We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$29.4B
AUM Growth
-$873M
Cap. Flow
+$534M
Cap. Flow %
1.81%
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$244M
2
ENPH icon
Enphase Energy
ENPH
+$229M
3
GSK icon
GSK
GSK
+$223M
4
ACN icon
Accenture
ACN
+$209M
5
C icon
Citigroup
C
+$209M

Sector Composition

Rank Sector Weight
1 Technology 21.48%
2 Healthcare 13.67%
3 Financials 9.64%
4 Industrials 8.71%
5 Consumer Discretionary 6.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEY
2276
DELISTED
ADDvantage Technologies Group
AEY
$62K ﹤0.01%
+3,536
New +$59.3K
EGLX
2277
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$62K ﹤0.01%
+70,927
New +$109K
ACTG icon
2278
Acacia Research
ACTG
$470M
$60K ﹤0.01%
14,745
-82,448
-85% -$381K
MMAT
2279
DELISTED
Meta Materials Inc. Common Stock
MMAT
$60K ﹤0.01%
+931
New +$81.5K
NNVC icon
2280
NanoViricides
NNVC
$36.2M
$59K ﹤0.01%
+34,193
New +$74.6K
ONCO icon
2281
Onconetix
ONCO
$3.29M
0
VOR icon
2282
Vor Biopharma
VOR
$1.28B
$58K ﹤0.01%
+730
New +$71.8K
NAGE
2283
Niagen Bioscience
NAGE
$247M
$58K ﹤0.01%
46,925
-124,672
-73% -$201K
AUD
2284
DELISTED
Audacy, Inc.
AUD
$58K ﹤0.01%
151,007
+4,077
+3% +$2.46K
ADV icon
2285
Advantage Solutions
ADV
$361M
$55K ﹤0.01%
+1,033
New +$95.2K
FTH
2286
Faeth Therapeutics
FTH
$629M
$55K ﹤0.01%
1,789
-150
-8% -$5.89K
RNWK
2287
DELISTED
RealNetworks Inc
RNWK
$55K ﹤0.01%
79,274
AREC icon
2288
American Resources Corp
AREC
$293M
$54K ﹤0.01%
+20,363
New +$49.8K
SYRE icon
2289
Spyre Therapeutics
SYRE
$9.25B
$54K ﹤0.01%
4,144
-8,490
-67% -$105K
ASMB icon
2290
Assembly Biosciences
ASMB
$529M
$53K ﹤0.01%
2,672
-2,531
-49% -$61.2K
CWBR
2291
DELISTED
CohBar, Inc. Common Stock
CWBR
$53K ﹤0.01%
18,416
-9,778
-35% -$49K
FABC
2292
Fabric.AI Inc
FABC
$18.4M
$52K ﹤0.01%
691
-116
-14% -$13.3K
HOOK
2293
DELISTED
HOOKIPA Pharma
HOOK
$51K ﹤0.01%
+3,787
New +$58.1K
NUWE icon
2294
Nuwellis
NUWE
$543K
0
APTO
2295
DELISTED
Aptose Biosciences, Inc.
APTO
$51K ﹤0.01%
192
+26
+16% +$8.96K
CTHR
2296
DELISTED
Charles & Colvard Ltd
CTHR
$50K ﹤0.01%
5,204
-82
-2% -$1.01K
TRUE
2297
DELISTED
TrueCar
TRUE
$49K ﹤0.01%
+32,414
New +$73.9K
VAXX
2298
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$49K ﹤0.01%
24,947
-103,569
-81% -$216K
LFLY
2299
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$49K ﹤0.01%
+3,577
New +$199K
NVIV
2300
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$49K ﹤0.01%
+11,521
New +$63.1K

Similar funds

Two Sigma Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Two Sigma Investments held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Two Sigma Investments's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Two Sigma Investments's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
  • Two Sigma Investments added most to GSK in Q3 2022, an estimated $223M increase.
  • Two Sigma Investments's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
  • Two Sigma Investments fully exited Bank of America in Q3 2022, selling an estimated $225M.
  • Two Sigma Investments's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
  • Two Sigma Investments opened 582 new positions and closed 600 in Q3 2022.
  • Two Sigma Investments's portfolio value fell 2.9% quarter-over-quarter to $29.4B.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.